Cormorant Global Healthcare Master Fund
VC Fund
Cormorant Global Healthcare Master Fund is a hedge fund specializing in public equity markets in the healthcare sector.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Cormorant Global Healthcare Master Fund invests in
Stages Cormorant Global Healthcare Master Fund invests in
Countries Cormorant Global Healthcare Master Fund invests in
Investment Focus
Industry
- Biopharma 2 (50%)
- Health Care 2 (50%)
- Therapeutics 2 (50%)
- Biotechnology 2 (50%)
- Pharmaceutical 2 (50%)
Stage
- Funding Round 2 (50%)
- Series A 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Interius BioTherapeutics is a biopharmaceutical company that targets cancer. The company spun out the University of Pennsylvania and is targeting cancer. | $21.5M / Jan 01, 2025 | ||
| Tioga Medical, a privately held portfolio company of Shifamed LLC, is focused on providing elegant valve replacement solutions for mitral and tricuspid applications that are procedurally simpler and use a less invasive, transcatheter approach. | $14.6M / Series A / Apr 01, 2019 | ||
| Outlook Therapeutics is a biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics. It is advancing its pipeline of 11 biosimilar products, two of which are currently in clinical development. The company employs its BioSymphony biosimilars business model to achieve accelerated development andtechnical excellence in order to create affordable medicines for patients around the world. | Sep 29, 2015 | ||
| Outlook Therapeutics is a biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics. It is advancing its pipeline of 11 biosimilar products, two of which are currently in clinical development. The company employs its BioSymphony biosimilars business model to achieve accelerated development andtechnical excellence in order to create affordable medicines for patients around the world. | $31M / Jul 27, 2015 |
Co-Investors
Perceptive Advisors
2 deals together
venBio Partners
2 deals together
Agent Capital
1 deal together
AMED Ventures
1 deal together
Bain Capital Life Sciences
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cormorant Global Healthcare Master Fund invest in?
Cormorant Global Healthcare Master Fund invests primarily in Biopharma, Health Care and Therapeutics startups, most often at Funding Round and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Cormorant Global Healthcare Master Fund last invest?
The most recent investment recorded for Cormorant Global Healthcare Master Fund closed in Jan 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
